Literature DB >> 18000728

Three-year results of Roux-en-Y gastric bypass-on-vertical banded gastroplasty: an effective and safe procedure which enables endoscopy and X-ray study of the stomach and biliary tract.

Stefano Cariani1, Enrico Amenta.   

Abstract

BACKGROUND: Cancer, perforation and bleeding in the bypassed stomach after RYGBP are rare but serious complications that require early diagnosis. Our goal was to perform a Roux-en-Y gastric bypass (RYGBP) whereby the traditional endoscopic and x-ray study of the bypassed stomach was possible, and at the same time obtain a good weight loss, similar to the standard RYGBP. We developed the RYGBP-on-Vertical banded gastroplasty (RYGBP on VBG), where a Goretex band surrounds the gastro-gastric outlet.
METHODS: From June 2002 to September 2005, 128 patients, 94 female and 34 male, with age 50.5 +/- 14.8 SD years, BMI 51.6 +/- 7.2 SD kg/m2, and %EW 117.9 +/- 33.5 SD underwent RYGBP on VBG via an open approach. Radiological and, if necessary, endoscopic study has been carried out at 6 months, 1 year and then annually postoperatively.
RESULTS: Two cases of anastomotic ulcer were detected, but no case of infection of the prosthetic material was found. Preoperative BMI fell from 51.6 +/- 7.2 to 38.1 +/- 6.6 after 6 months, to 35.0 +/- 7.1 after 1 year, to 34.4 +/- 6.1 after 2 years, and to 33.2 +/- 5.5 after 3 years.
CONCLUSION: RYGBP on VBG was effective; the weight loss curve, compared to standard RYGBP, is similar, while allowing the traditional x-ray and endoscopy of the bypassed stomach and thus the biliary tract.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18000728     DOI: 10.1007/s11695-007-9234-8

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  29 in total

1.  Technical Strategies for Converting the Failed Vertical Banded Gastroplasty to the Roux-en-Y Gastric Bypass.

Authors: 
Journal:  Obes Surg       Date:  1993-11       Impact factor: 4.129

2.  Cancer in the excluded stomach 4 years after gastric bypass.

Authors:  Deborah A Corsini; Celso A M Simoneti; Gisele Moreira; Sizenando E Lima; Arthur B Garrido
Journal:  Obes Surg       Date:  2006-07       Impact factor: 4.129

3.  Reducing early technical complications in gastric bypass surgery.

Authors:  R F Capella; J F Capella
Journal:  Obes Surg       Date:  1997-04       Impact factor: 4.129

4.  Double-balloon enteroscopy (push-and-pull enteroscopy) of the small bowel: feasibility and diagnostic and therapeutic yield in patients with suspected small bowel disease.

Authors:  Andrea May; Lars Nachbar; Christian Ell
Journal:  Gastrointest Endosc       Date:  2005-07       Impact factor: 9.427

5.  Report of two cases of gastric cancer after bariatric surgery: lymphoma of the bypassed stomach after Roux-en-Y gastric bypass and gastrointestinal stromal tumor (GIST) after vertical banded gastroplasty.

Authors:  Arnaud de Roover; Olivier Detry; Laurence de Leval; Carla Coimbra; Claude Desaive; Pierre Honoré; Michel Meurisse
Journal:  Obes Surg       Date:  2006-07       Impact factor: 4.129

6.  Use of double-balloon enteroscopy to perform PEG in the excluded stomach after Roux-en-Y gastric bypass.

Authors:  Andrew S Ross; Carol Semrad; John Alverdy; Irving Waxman; Charles Dye
Journal:  Gastrointest Endosc       Date:  2006-11       Impact factor: 9.427

7.  Bleeding from the bypassed stomach following gastric bypass.

Authors:  K J Printen; J LeFavre; J Alden
Journal:  Surg Gynecol Obstet       Date:  1983-01

8.  Revisional Surgery for Failed Gastric Restrictive Procedures for Morbid Obesity.

Authors: 
Journal:  Obes Surg       Date:  1992-08       Impact factor: 4.129

9.  Excellent weight result after Roux-en-Y gastric bypass in spite of gastro-gastric fistula.

Authors:  Sven Gustavsson; Magnus Sundbom
Journal:  Obes Surg       Date:  2003-06       Impact factor: 4.129

10.  Late gastrointestinal hemorrhage after gastric bypass.

Authors:  Scott C Braley; Ninh T Nguyen; Bruce M Wolfe
Journal:  Obes Surg       Date:  2002-06       Impact factor: 4.129

View more
  7 in total

1.  Laparoscopic sleeve gastrectomy with duodeno-jejunal bypass: a new surgical procedure for weight control. Feasibility and safety study in a porcine model.

Authors:  Gianmattia Del Genio; Michel Gagner; Federico Cuenca-Abente; David Nocca; Laurent Biertho; Federica Del Genio; Ahmad Assalia; Alberto Del Genio
Journal:  Obes Surg       Date:  2008-06-18       Impact factor: 4.129

2.  Laparoscopic Roux-en-Y Gastric Bypass for Failed Vertical Banded Gastroplasty.

Authors:  Mahmoud Zakaria; Ahmad Elhoofy
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

3.  Visceral fat and body composition changes in a female population after RYGBP: a two-year follow-up by DXA.

Authors:  Alberto Bazzocchi; Federico Ponti; Stefano Cariani; Danila Diano; Luca Leuratti; Ugo Albisinni; Giulio Marchesini; Giuseppe Battista
Journal:  Obes Surg       Date:  2015-03       Impact factor: 4.129

4.  Unexpected changes in the gastric remnant in asymptomatic patients after Roux-en-Y gastric bypass on vertical banded gastroplasty.

Authors:  Luca Leuratti; Massimo Pierluigi Di Simone; Stefano Cariani
Journal:  Obes Surg       Date:  2013-01       Impact factor: 4.129

5.  Failure of gastric bypass following several gastrointestinal hemorrhages.

Authors:  Enrico Mozzi; Ezio Lattuada; Marco Antonio Zappa; Ilaria Antonini; Francesco Andreoli; Sara Badiali; Giancarlo Roviaro
Journal:  Obes Surg       Date:  2008-07-19       Impact factor: 4.129

6.  Bariatric Revisionary Surgery for Failed or Complicated Vertical Banded Gastroplasty (VBG): Comparison of VBG Reoperation (re-VBG) versus Roux-en-Y Gastric Bypass-on-VBG (RYGB-on-VBG).

Authors:  Stefano Cariani; Laura Agostinelli; Luca Leuratti; Eleonora Giorgini; Pietro Biondi; Enrico Amenta
Journal:  J Obes       Date:  2009-12-06

7.  Influence of obesity and bariatric surgery on gastric cancer.

Authors:  Anna Carolina Batista Dantas; Marco Aurelio Santo; Roberto de Cleva; Rubens Antônio Aissar Sallum; Ivan Cecconello
Journal:  Cancer Biol Med       Date:  2016-06       Impact factor: 4.248

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.